Predicting risk of pelvic floor disorders 12 and 20 years after delivery
Little progress has been made in the prevention of pelvic floor disorders, despite their significant health and economic impact. The identification of women who are at risk remains a key element in targeting prevention and planning health resource allocation strategies. Although events around the ti...
Saved in:
Published in | American journal of obstetrics and gynecology Vol. 218; no. 2; pp. 222.e1 - 222.e19 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.02.2018
|
Subjects | |
Online Access | Get full text |
ISSN | 0002-9378 1097-6868 1097-6868 |
DOI | 10.1016/j.ajog.2017.10.014 |
Cover
Abstract | Little progress has been made in the prevention of pelvic floor disorders, despite their significant health and economic impact. The identification of women who are at risk remains a key element in targeting prevention and planning health resource allocation strategies. Although events around the time of childbirth are recognized clinically as important predictors, it is difficult to counsel women and to intervene around the time of childbirth because of an inability to convey a patient’s risk accurately in the presence of multiple risk factors and the long time lapse, which is often decades, between obstetric events and the onset of pelvic floor disorders later in life. Prediction models and scoring systems have been used in other areas of medicine to identify patients who are at risk for chronic diseases. Models have been developed for use before delivery that predict short-term risk of pelvic floor disorders after childbirth, but no models that predict long-term risk exist.
The purpose of this study was to use variables that are known before and during childbirth to develop and validate prognostic models that will estimate the risks of these disorders 12 and 20 years after delivery.
Obstetric variables were collected from 2 cohorts: (1) women who gave birth in the United Kingdom and New Zealand (n=3763) and (2) women from the Swedish Medical Birth Register (n=4991). Pelvic floor disorders were self-reported 12 years after childbirth in the United Kingdom/New Zealand cohort and 20 years after childbirth in the Swedish Register. The cohorts were split so that data during the first half of the cohort’s time period were used to fit prediction models, and validation was performed from the second half (temporal validation). Because there is currently no consensus on how to best define pelvic floor disorders from a patient’s perspective, we chose to fit the data for each model using multiple outcome definitions for prolapse, urinary incontinence, fecal incontinence, ≥1 pelvic floor disorder, and ≥2 pelvic floor disorders. Model accuracy was measured in the following manner: (1) by ranking an individual’s risk among all subjects in the cohort (discrimination) with the use of a concordance index and (2) by observing whether the predicted probability was too high or low (calibration) at a range of predicted probabilities with the use of visual plots.
Models were able to discriminate between women who experienced bothersome symptoms or received treatment at 12 and 20 years, respectively, for pelvic organ prolapse (concordance indices, 0.570, 0.627), urinary incontinence (concordance indices, 0.653, 0.689), fecal incontinence (concordance indices, 0.618, 0.676), ≥1 pelvic floor disorders (concordance indices, 0.639, 0.675), and ≥2 pelvic floor disorders (concordance indices, 0.635, 0.619). Route of delivery and family history of each pelvic floor disorder were strong predictors in most models. Urinary incontinence before and during the index pregnancy was a strong predictor for the development of all pelvic floor disorders in most models 12 years after delivery. The 12- and 20-year bothersome symptoms or treatment for prolapse models were accurate when predictions were provided for risk from 0% to approximately 15%. The 12- and 20-year primiparous model began to over predict when risk rates reached 20%. When we predicted bothersome symptoms or treatment for urinary incontinence, the 12-year models were accurate when predictions ranged from approximately 5–60%; the 20-year primiparous models were accurate from 5% and 80%. For bothersome symptoms or treatment for fecal incontinence, the 12- and 20-year models were accurate from 1–15% risk and began to over predict at rates at >15% and 20%, respectively.
Models may provide an opportunity before birth to identify women who are at low risk of the development of pelvic floor disorders and may provide institute prevention strategies such as pelvic floor muscle training, weight control, or elective cesarean section for women who are at higher risk. Models are provided at http://riskcalc.org/UR_CHOICE/. |
---|---|
AbstractList | Little progress has been made in the prevention of pelvic floor disorders, despite their significant health and economic impact. The identification of women who are at risk remains a key element in targeting prevention and planning health resource allocation strategies. Although events around the time of childbirth are recognized clinically as important predictors, it is difficult to counsel women and to intervene around the time of childbirth because of an inability to convey a patient's risk accurately in the presence of multiple risk factors and the long time lapse, which is often decades, between obstetric events and the onset of pelvic floor disorders later in life. Prediction models and scoring systems have been used in other areas of medicine to identify patients who are at risk for chronic diseases. Models have been developed for use before delivery that predict short-term risk of pelvic floor disorders after childbirth, but no models that predict long-term risk exist.BACKGROUNDLittle progress has been made in the prevention of pelvic floor disorders, despite their significant health and economic impact. The identification of women who are at risk remains a key element in targeting prevention and planning health resource allocation strategies. Although events around the time of childbirth are recognized clinically as important predictors, it is difficult to counsel women and to intervene around the time of childbirth because of an inability to convey a patient's risk accurately in the presence of multiple risk factors and the long time lapse, which is often decades, between obstetric events and the onset of pelvic floor disorders later in life. Prediction models and scoring systems have been used in other areas of medicine to identify patients who are at risk for chronic diseases. Models have been developed for use before delivery that predict short-term risk of pelvic floor disorders after childbirth, but no models that predict long-term risk exist.The purpose of this study was to use variables that are known before and during childbirth to develop and validate prognostic models that will estimate the risks of these disorders 12 and 20 years after delivery.OBJECTIVEThe purpose of this study was to use variables that are known before and during childbirth to develop and validate prognostic models that will estimate the risks of these disorders 12 and 20 years after delivery.Obstetric variables were collected from 2 cohorts: (1) women who gave birth in the United Kingdom and New Zealand (n=3763) and (2) women from the Swedish Medical Birth Register (n=4991). Pelvic floor disorders were self-reported 12 years after childbirth in the United Kingdom/New Zealand cohort and 20 years after childbirth in the Swedish Register. The cohorts were split so that data during the first half of the cohort's time period were used to fit prediction models, and validation was performed from the second half (temporal validation). Because there is currently no consensus on how to best define pelvic floor disorders from a patient's perspective, we chose to fit the data for each model using multiple outcome definitions for prolapse, urinary incontinence, fecal incontinence, ≥1 pelvic floor disorder, and ≥2 pelvic floor disorders. Model accuracy was measured in the following manner: (1) by ranking an individual's risk among all subjects in the cohort (discrimination) with the use of a concordance index and (2) by observing whether the predicted probability was too high or low (calibration) at a range of predicted probabilities with the use of visual plots.STUDY DESIGNObstetric variables were collected from 2 cohorts: (1) women who gave birth in the United Kingdom and New Zealand (n=3763) and (2) women from the Swedish Medical Birth Register (n=4991). Pelvic floor disorders were self-reported 12 years after childbirth in the United Kingdom/New Zealand cohort and 20 years after childbirth in the Swedish Register. The cohorts were split so that data during the first half of the cohort's time period were used to fit prediction models, and validation was performed from the second half (temporal validation). Because there is currently no consensus on how to best define pelvic floor disorders from a patient's perspective, we chose to fit the data for each model using multiple outcome definitions for prolapse, urinary incontinence, fecal incontinence, ≥1 pelvic floor disorder, and ≥2 pelvic floor disorders. Model accuracy was measured in the following manner: (1) by ranking an individual's risk among all subjects in the cohort (discrimination) with the use of a concordance index and (2) by observing whether the predicted probability was too high or low (calibration) at a range of predicted probabilities with the use of visual plots.Models were able to discriminate between women who experienced bothersome symptoms or received treatment at 12 and 20 years, respectively, for pelvic organ prolapse (concordance indices, 0.570, 0.627), urinary incontinence (concordance indices, 0.653, 0.689), fecal incontinence (concordance indices, 0.618, 0.676), ≥1 pelvic floor disorders (concordance indices, 0.639, 0.675), and ≥2 pelvic floor disorders (concordance indices, 0.635, 0.619). Route of delivery and family history of each pelvic floor disorder were strong predictors in most models. Urinary incontinence before and during the index pregnancy was a strong predictor for the development of all pelvic floor disorders in most models 12 years after delivery. The 12- and 20-year bothersome symptoms or treatment for prolapse models were accurate when predictions were provided for risk from 0% to approximately 15%. The 12- and 20-year primiparous model began to over predict when risk rates reached 20%. When we predicted bothersome symptoms or treatment for urinary incontinence, the 12-year models were accurate when predictions ranged from approximately 5-60%; the 20-year primiparous models were accurate from 5% and 80%. For bothersome symptoms or treatment for fecal incontinence, the 12- and 20-year models were accurate from 1-15% risk and began to over predict at rates at >15% and 20%, respectively.RESULTSModels were able to discriminate between women who experienced bothersome symptoms or received treatment at 12 and 20 years, respectively, for pelvic organ prolapse (concordance indices, 0.570, 0.627), urinary incontinence (concordance indices, 0.653, 0.689), fecal incontinence (concordance indices, 0.618, 0.676), ≥1 pelvic floor disorders (concordance indices, 0.639, 0.675), and ≥2 pelvic floor disorders (concordance indices, 0.635, 0.619). Route of delivery and family history of each pelvic floor disorder were strong predictors in most models. Urinary incontinence before and during the index pregnancy was a strong predictor for the development of all pelvic floor disorders in most models 12 years after delivery. The 12- and 20-year bothersome symptoms or treatment for prolapse models were accurate when predictions were provided for risk from 0% to approximately 15%. The 12- and 20-year primiparous model began to over predict when risk rates reached 20%. When we predicted bothersome symptoms or treatment for urinary incontinence, the 12-year models were accurate when predictions ranged from approximately 5-60%; the 20-year primiparous models were accurate from 5% and 80%. For bothersome symptoms or treatment for fecal incontinence, the 12- and 20-year models were accurate from 1-15% risk and began to over predict at rates at >15% and 20%, respectively.Models may provide an opportunity before birth to identify women who are at low risk of the development of pelvic floor disorders and may provide institute prevention strategies such as pelvic floor muscle training, weight control, or elective cesarean section for women who are at higher risk. Models are provided at http://riskcalc.org/UR_CHOICE/.CONCLUSIONModels may provide an opportunity before birth to identify women who are at low risk of the development of pelvic floor disorders and may provide institute prevention strategies such as pelvic floor muscle training, weight control, or elective cesarean section for women who are at higher risk. Models are provided at http://riskcalc.org/UR_CHOICE/. Little progress has been made in the prevention of pelvic floor disorders, despite their significant health and economic impact. The identification of women who are at risk remains a key element in targeting prevention and planning health resource allocation strategies. Although events around the time of childbirth are recognized clinically as important predictors, it is difficult to counsel women and to intervene around the time of childbirth because of an inability to convey a patient’s risk accurately in the presence of multiple risk factors and the long time lapse, which is often decades, between obstetric events and the onset of pelvic floor disorders later in life. Prediction models and scoring systems have been used in other areas of medicine to identify patients who are at risk for chronic diseases. Models have been developed for use before delivery that predict short-term risk of pelvic floor disorders after childbirth, but no models that predict long-term risk exist. The purpose of this study was to use variables that are known before and during childbirth to develop and validate prognostic models that will estimate the risks of these disorders 12 and 20 years after delivery. Obstetric variables were collected from 2 cohorts: (1) women who gave birth in the United Kingdom and New Zealand (n=3763) and (2) women from the Swedish Medical Birth Register (n=4991). Pelvic floor disorders were self-reported 12 years after childbirth in the United Kingdom/New Zealand cohort and 20 years after childbirth in the Swedish Register. The cohorts were split so that data during the first half of the cohort’s time period were used to fit prediction models, and validation was performed from the second half (temporal validation). Because there is currently no consensus on how to best define pelvic floor disorders from a patient’s perspective, we chose to fit the data for each model using multiple outcome definitions for prolapse, urinary incontinence, fecal incontinence, ≥1 pelvic floor disorder, and ≥2 pelvic floor disorders. Model accuracy was measured in the following manner: (1) by ranking an individual’s risk among all subjects in the cohort (discrimination) with the use of a concordance index and (2) by observing whether the predicted probability was too high or low (calibration) at a range of predicted probabilities with the use of visual plots. Models were able to discriminate between women who experienced bothersome symptoms or received treatment at 12 and 20 years, respectively, for pelvic organ prolapse (concordance indices, 0.570, 0.627), urinary incontinence (concordance indices, 0.653, 0.689), fecal incontinence (concordance indices, 0.618, 0.676), ≥1 pelvic floor disorders (concordance indices, 0.639, 0.675), and ≥2 pelvic floor disorders (concordance indices, 0.635, 0.619). Route of delivery and family history of each pelvic floor disorder were strong predictors in most models. Urinary incontinence before and during the index pregnancy was a strong predictor for the development of all pelvic floor disorders in most models 12 years after delivery. The 12- and 20-year bothersome symptoms or treatment for prolapse models were accurate when predictions were provided for risk from 0% to approximately 15%. The 12- and 20-year primiparous model began to over predict when risk rates reached 20%. When we predicted bothersome symptoms or treatment for urinary incontinence, the 12-year models were accurate when predictions ranged from approximately 5–60%; the 20-year primiparous models were accurate from 5% and 80%. For bothersome symptoms or treatment for fecal incontinence, the 12- and 20-year models were accurate from 1–15% risk and began to over predict at rates at >15% and 20%, respectively. Models may provide an opportunity before birth to identify women who are at low risk of the development of pelvic floor disorders and may provide institute prevention strategies such as pelvic floor muscle training, weight control, or elective cesarean section for women who are at higher risk. Models are provided at http://riskcalc.org/UR_CHOICE/. Little progress has been made in preventing pelvic floor disorders despite their significant health and economic impact. Identifying women at risk remains a key element in targeting prevention and planning health resource allocation strategies. Although events around the time of childbirth are clinically recognized as important predictors, it is difficult to counsel women and intervene around the time of childbirth due to an inability to accurately convey a patient's risk in the presence of multiple risk factors and the long time lapse, often decades, between obstetric events and the onset of pelvic floor disorders later in life. Prediction models and scoring systems have been used in other areas of medicine to identify patients at risk for chronic diseases. Models have been developed for use before delivery that predict short-term risk of pelvic floor disorders after childbirth but no models predicting long-term risk exist.To use variables known before and during childbirth to develop and validate prognostic models estimating risks of these disorders 12 and 20 years after delivery.Obstetric variables were collected from two cohorts: 1) women who gave birth in the United Kingdom and New Zealand (n=3763) and 2) women from the Swedish Medical Birth Register (n=4991). Pelvic floor disorders were self-reported 12 years after childbirth in the UK/NZ cohort and 20 years after childbirth in the Swedish Register. The cohorts were split so that data during the first half of the cohort's time period were used to fit prediction models and validation was performed from the second half (temporal validation). As there is currently no consensus on how to best define pelvic floor disorders from a patient's perspective, we chose to fit the data for each model using multiple outcome definitions for prolapse, urinary incontinence, fecal incontinence, 1 or more pelvic floor disorder and 2 or more pelvic floor disorders. Model accuracy was measured: 1) by ranking an individual's risk among all subjects in the cohort (discrimination) using a concordance index and 2) by observing whether the predicted probability was too high or low (calibration) at a range of predicted probabilities using visual plots.Models were able to discriminate between women who developed bothersome symptoms or received treatment, at 12 and 20 years respectively, for: pelvic organ prolapse (concordance indices 0.570, 0.627), urinary incontinence (concordance indices 0.653, 0.689), fecal incontinence (concordance indices 0.618, 0.676), ≥1 pelvic floor disorders (concordance indices 0.639, 0.675) and ≥2 pelvic floor disorders (concordance indices 0.635, 0.619). The discriminatory ability of all models is shown in Table 2. Route of delivery and family history of each pelvic floor disorder were strong predictors in most models. Urinary incontinence before and during the index pregnancy was a strong predictor for developing all pelvic floor disorders in most models 12 years after delivery. The 12 and 20-year bothersome or treatment for prolapse models were accurate when providing predictions for risk from 0% to approximately 15%. The 12-year and 20-year primiparous model began to over-predict when risk rates reached 20%. When predicting bothersome symptoms or treatment for urinary incontinence, the 12-year models were accurate when predictions ranged from approximately 5% to 60% and 20-year primiparous models were accurate between 5% and 80%. For bothersome symptoms or treatment for fecal incontinence, the 12 and 20-year models were accurate between 1% and 15% risk and began to over-predict at rates above 15% and 20%, respectively.Models may provide an opportunity before birth to identify women at low risk of developing pelvic floor disorders and institute prevention strategies such as pelvic floor muscle training, weight control or elective cesarean section for women at higher risk. Models are provided at: http://riskcalc.org/UR_CHOICE/. |
Author | MacArthur, Christine Hagen, Suzanne Gyhagen, Maria Wilson, Don Jelovsek, J. Eric Chagin, Kevin Barber, Matthew D. Kattan, Michael W. Elders, Andrew Areskoug, Björn Milsom, Ian |
Author_xml | – sequence: 1 givenname: J. Eric surname: Jelovsek fullname: Jelovsek, J. Eric email: eric.jelovsek@duke.edu organization: Obstetrics, Gynecology & Women’s Health Institute and Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, and Department of Obstetrics & Gynecology, Duke University, Durham, North Carolina, United States – sequence: 2 givenname: Kevin surname: Chagin fullname: Chagin, Kevin organization: Obstetrics, Gynecology & Women’s Health Institute and Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, and Department of Obstetrics & Gynecology, Duke University, Durham, North Carolina, United States – sequence: 3 givenname: Maria surname: Gyhagen fullname: Gyhagen, Maria organization: Department of Obstetrics & Gynecology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden – sequence: 4 givenname: Suzanne orcidid: 0000-0002-9741-9160 surname: Hagen fullname: Hagen, Suzanne organization: Nursing, Midwifery and Allied Health Professions Research Unit, Glasgow Caledonian University, Glasgow, UK – sequence: 5 givenname: Don surname: Wilson fullname: Wilson, Don organization: University of Otago, Dunedin, New Zealand – sequence: 6 givenname: Michael W. surname: Kattan fullname: Kattan, Michael W. organization: Obstetrics, Gynecology & Women’s Health Institute and Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, and Department of Obstetrics & Gynecology, Duke University, Durham, North Carolina, United States – sequence: 7 givenname: Andrew orcidid: 0000-0003-4172-4702 surname: Elders fullname: Elders, Andrew organization: Nursing, Midwifery and Allied Health Professions Research Unit, Glasgow Caledonian University, Glasgow, UK – sequence: 8 givenname: Matthew D. surname: Barber fullname: Barber, Matthew D. organization: Obstetrics, Gynecology & Women’s Health Institute and Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, and Department of Obstetrics & Gynecology, Duke University, Durham, North Carolina, United States – sequence: 9 givenname: Björn surname: Areskoug fullname: Areskoug, Björn organization: Department of Obstetrics & Gynecology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden – sequence: 10 givenname: Christine surname: MacArthur fullname: MacArthur, Christine organization: Institute of Applied Health Research, University of Birmingham, Birmingham, UK – sequence: 11 givenname: Ian surname: Milsom fullname: Milsom, Ian organization: Department of Obstetrics & Gynecology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29056536$$D View this record in MEDLINE/PubMed https://gup.ub.gu.se/publication/258814$$DView record from Swedish Publication Index |
BookMark | eNqFkUFv3CAQhVGUKtmk_QM9VBx78RawsaHqpYrapFKk9pCcEYZhxYY1Lthb7b8vziY95JCe0Dy-9zSad4FOhzgAQu8pWVNC20_btd7GzZoR2hVhTWhzglaUyK5qRStO0YoQwipZd-IcXeS8XUYm2Rk6Z5LwltftCt38SmC9mfywwcnnBxwdHiHsvcEuxJiw9TkmCyljyrAeLGYEH0CXWbsJyj8Ev4d0eIveOB0yvHt6L9H99293VzfV7c_rH1dfbyvTCDlV2jLDe9m5upXWCMN4bRvbEd6JXlDBZG2d7B3jzDnmqLHasNoCOO76pmlZfYmqY27-A-PcqzH5nU4HFbVXm3lURdrMKoNiXAjaFP7jkR9T_D1DntTOZwMh6AHinBWVvKmlIA0v6IcndO53YP9FP1-rAOIImBRzTuCU8ZOefBympH1QlKilGLVVSzFqKWbRyOMa7IX1Of1V05ejCcpB9x6SysbDYEpjCcykbPSv2z-_sJvgB290eIDD_8x_AdsjugI |
CitedBy_id | crossref_primary_10_1007_s00404_018_4970_7 crossref_primary_10_1016_j_ucl_2018_08_008 crossref_primary_10_1097_SPV_0000000000001556 crossref_primary_10_1002_jum_16295 crossref_primary_10_1111_aogs_14027 crossref_primary_10_3310_NWTB5403 crossref_primary_10_1002_nau_24124 crossref_primary_10_1007_s00192_021_04797_9 crossref_primary_10_1055_s_0043_1764196 crossref_primary_10_1016_j_gtc_2021_10_011 crossref_primary_10_1007_s00192_021_04804_z crossref_primary_10_1097_SPV_0000000000000941 crossref_primary_10_1055_a_1515_2622 crossref_primary_10_1016_j_cont_2022_100502 crossref_primary_10_1007_s00404_023_07174_7 crossref_primary_10_1016_j_heliyon_2025_e42018 crossref_primary_10_1097_MD_0000000000025796 crossref_primary_10_1016_j_ejogrb_2021_04_006 crossref_primary_10_1186_s12884_022_04490_9 crossref_primary_10_1177_17562872221090319 crossref_primary_10_1177_0300060520914226 crossref_primary_10_1002_nau_70019 crossref_primary_10_1007_s00129_020_04708_x crossref_primary_10_1007_s00129_022_05029_x crossref_primary_10_1097_SPV_0000000000000953 crossref_primary_10_1111_1471_0528_18119 crossref_primary_10_1007_s40141_020_00273_5 crossref_primary_10_1186_s12938_025_01366_9 crossref_primary_10_1055_a_1631_3567 crossref_primary_10_2147_IJWH_S367110 crossref_primary_10_1016_j_ejogrb_2020_01_049 crossref_primary_10_1002_14651858_CD004010_pub4 crossref_primary_10_1016_j_jogoh_2021_102068 crossref_primary_10_1016_j_ajog_2018_10_013 crossref_primary_10_1038_s41467_022_31188_5 crossref_primary_10_4103_abr_abr_168_22 crossref_primary_10_1016_j_ejogrb_2020_07_023 crossref_primary_10_29254_2077_4214_2023_3_170_257_264 crossref_primary_10_1016_j_diabres_2020_108315 crossref_primary_10_1016_j_esxm_2021_100417 crossref_primary_10_1089_gyn_2022_0049 crossref_primary_10_1111_1471_0528_16322 crossref_primary_10_1007_s43032_023_01424_4 crossref_primary_10_1007_s00192_020_04559_z crossref_primary_10_1016_j_cont_2025_101746 crossref_primary_10_1097_SPV_0000000000001068 crossref_primary_10_1111_hex_14033 crossref_primary_10_1016_j_ajog_2019_12_271 crossref_primary_10_1016_j_gofs_2018_10_030 crossref_primary_10_1002_nau_24053 crossref_primary_10_1007_s00404_019_05073_4 crossref_primary_10_1016_j_ajog_2020_08_033 crossref_primary_10_1007_s00404_019_05311_9 crossref_primary_10_1016_j_tjog_2020_11_011 crossref_primary_10_1111_birt_12777 crossref_primary_10_1186_s12889_023_17065_w crossref_primary_10_1007_s00192_020_04552_6 crossref_primary_10_3390_ijms24076087 crossref_primary_10_1016_j_bpobgyn_2018_05_004 crossref_primary_10_1002_jum_16627 |
Cites_doi | 10.1056/NEJMoa0801869 10.1016/S0140-6736(16)32109-2 10.1111/j.1464-410X.2008.07601.x 10.1177/0272989X15581615 10.1007/BF02050307 10.1111/j.1471-0528.2012.03301.x 10.1016/j.jclinepi.2014.11.010 10.1007/s00192-014-2376-z 10.1097/SPV.0b013e31828508f0 10.1016/j.jclinepi.2004.06.008 10.1097/01.AOG.0000241092.79282.87 10.1007/978-1-4757-3462-1 10.1002/sim.4067 10.1016/j.ajog.2015.02.017 10.1111/j.1471-0528.2011.02964.x 10.1097/AOG.0000000000000094 10.1093/jnci/93.5.358 10.1111/1471-0528.12020 10.1136/jech.47.6.497 10.1001/jama.286.2.180 10.1136/bmj.h1481 10.1097/AOG.0000000000000286 10.7326/0003-4819-148-6-200803180-00210 10.1111/j.1471-0528.2008.01903.x |
ContentType | Journal Article |
Copyright | 2017 Elsevier Inc. Copyright © 2017 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2017 Elsevier Inc. – notice: Copyright © 2017 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 ADTPV AOWAS F1U |
DOI | 10.1016/j.ajog.2017.10.014 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic SwePub SwePub Articles SWEPUB Göteborgs universitet |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-6868 |
EndPage | 222.e19 |
ExternalDocumentID | oai_gup_ub_gu_se_258814 29056536 10_1016_j_ajog_2017_10_014 S000293781731205X |
Genre | Validation Study Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Chief Scientist Office grantid: NMAHP2 |
GroupedDBID | --- --K --M -ET .1- .55 .FO .GJ .XZ .~1 0R~ 1B1 1CY 1P~ 1~. 1~5 23M 2KS 354 3O- 4.4 457 4CK 4G. 53G 5GY 5RE 5VS 6J9 7-5 85S 8F7 8P~ AAEDT AAEDW AAIKC AAIKJ AAKOC AALRI AAMNW AAOAW AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYJJ AAYWO ABBQC ABCQX ABDPE ABFNM ABFRF ABJNI ABMAC ABMZM ABOCM ABPMR ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFCHL AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGNAY AGQPQ AGUBO AGYEJ AHDLI AI. AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 C5W CAG COF CS3 EBS EFJIC EFKBS EJD EO8 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IH2 IHE J1W K-O KOM LPU M41 MO0 N4W N9A NEJ NQ- O-L O9- OAUVE OBH OCB OGEVE OHH OHT OMK OQ. OVD P-8 P-9 P2P PC. PH~ Q38 R2- ROL RPZ RXW SDF SEL SES SEW SJN SPCBC SSH SSZ T5K TAE TEORI TWZ UDS UGJ UHB UHS UHU UKR UNMZH UV1 VH1 VVN WH7 WOQ WOW X6Y X7M XFW YFH YOC YYQ YZZ Z5R ZGI ZXP ZY1 ~G- ~H1 AACTN AFCTW RIG AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 EFLBG ADTPV AOWAS F1U |
ID | FETCH-LOGICAL-c489t-ad2c5b97f369dc8c253d4d70578b818293df9bf252ff2f1cdac23deef5fb44623 |
IEDL.DBID | AIKHN |
ISSN | 0002-9378 1097-6868 |
IngestDate | Tue Sep 09 23:26:06 EDT 2025 Thu Sep 04 19:01:20 EDT 2025 Mon Jul 21 06:04:06 EDT 2025 Tue Jul 01 05:17:44 EDT 2025 Thu Apr 24 22:59:16 EDT 2025 Sat Mar 29 16:10:41 EDT 2025 Tue Aug 26 17:15:35 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | prediction model pelvic floor disorder machine learning fecal incontinence pelvic organ prolapse urinary incontinence |
Language | English |
License | Copyright © 2017 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c489t-ad2c5b97f369dc8c253d4d70578b818293df9bf252ff2f1cdac23deef5fb44623 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0003-4172-4702 0000-0002-9741-9160 |
OpenAccessLink | https://research.birmingham.ac.uk/portal/en/publications/predicting-risk-of-pelvic-floor-disorders-12-and-20-years-after-delivery(530f7caf-71cf-4b33-98f8-68f03dbe88a0).html |
PMID | 29056536 |
PQID | 1954398045 |
PQPubID | 23479 |
ParticipantIDs | swepub_primary_oai_gup_ub_gu_se_258814 proquest_miscellaneous_1954398045 pubmed_primary_29056536 crossref_citationtrail_10_1016_j_ajog_2017_10_014 crossref_primary_10_1016_j_ajog_2017_10_014 elsevier_sciencedirect_doi_10_1016_j_ajog_2017_10_014 elsevier_clinicalkey_doi_10_1016_j_ajog_2017_10_014 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-02-01 |
PublicationDateYYYYMMDD | 2018-02-01 |
PublicationDate_xml | – month: 02 year: 2018 text: 2018-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | American journal of obstetrics and gynecology |
PublicationTitleAlternate | Am J Obstet Gynecol |
PublicationYear | 2018 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Moore, Wagner, Subak (bib3) 2012 Jorge, Wexner (bib22) 1993; 36 Sokol (bib25) 2015; 350 Hagen, Glazener, McClurg (bib28) 2017; 389 Tegerstedt, Miedel, Maehle-Schmidt, Nyren, Hammarstrom (bib20) 2005; 58 Haya, Baessler, Christmann-Schmid (bib4) 2015; 212 Gyhagen, Bullarbo, Nielsen, Milsom (bib13) 2013; 120 Visco, Viswanathan, Lohr (bib27) 2006; 108 Sandvik, Hunskaar, Seim, Hermstad, Vanvik, Bratt (bib21) 1993; 47 Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001. Milsom, Altman, Cartwright (bib1) 2013 Kattan, O’Rourke, Yu, Chagin (bib16) 2016; 36 Collins, Reitsma, Altman, Moons (bib17) 2015; 68 Wu, Matthews, Conover, Pate, Jonsson Funk (bib5) 2014; 123 Maher, Feiner, Baessler, Schmid (bib7) 2013; 4 NIDDK, Office of Research on Women’s H, National Institute on A. Prevention of Lower Urinary Tract Symptoms in Women: Bladder Health Clinical Centers (PLUS-CCs) (U01). National Institutes of Health, 2014 website Rockhill, Spiegelman, Byrne, Hunter, Colditz (bib30) 2001; 93 Hagen, Glazener, Sinclair, Stark, Bugge (bib19) 2009; 116 Landefeld, Bowers, Feld (bib26) 2008; 148 Lyssenko, Jonsson, Almgren (bib10) 2008; 359 D’Agostino, Grundy, Sullivan, Wilson (bib9) 2001; 286 Jelovsek, Piccorelli, Barber, Tunitsky-Bitton, Kattan (bib11) 2013; 19 Jelovsek, Chagin, Brubaker (bib15) 2014; 123 . Coyne, Sexton, Irwin, Kopp, Kelleher, Milsom (bib2) 2008; 101 MacArthur, Glazener, Lancashire, Herbison, Wilson (bib14) 2011; 118 Wilson, Dornan, Milsom, Freeman (bib12) 2014; 25 Ford, Rogerson, Cody, Ogah (bib6) 2015 White, Royston, Wood (bib23) 2011; 30 National Cancer I. Theory at a glance: a guide for health promotion practice. US Department of Health and Human Services, National Institutes of Health; 2012 (vol 2016). Gyhagen, Bullarbo, Nielsen, Milsom (bib18) 2013; 120 10.1016/j.ajog.2017.10.014_bib8 Gyhagen (10.1016/j.ajog.2017.10.014_bib13) 2013; 120 10.1016/j.ajog.2017.10.014_bib29 Moore (10.1016/j.ajog.2017.10.014_bib3) 2012 Kattan (10.1016/j.ajog.2017.10.014_bib16) 2016; 36 Wu (10.1016/j.ajog.2017.10.014_bib5) 2014; 123 D’Agostino (10.1016/j.ajog.2017.10.014_bib9) 2001; 286 MacArthur (10.1016/j.ajog.2017.10.014_bib14) 2011; 118 Jelovsek (10.1016/j.ajog.2017.10.014_bib11) 2013; 19 Visco (10.1016/j.ajog.2017.10.014_bib27) 2006; 108 Sandvik (10.1016/j.ajog.2017.10.014_bib21) 1993; 47 Hagen (10.1016/j.ajog.2017.10.014_bib28) 2017; 389 Gyhagen (10.1016/j.ajog.2017.10.014_bib18) 2013; 120 Ford (10.1016/j.ajog.2017.10.014_bib6) 2015 Hagen (10.1016/j.ajog.2017.10.014_bib19) 2009; 116 Jorge (10.1016/j.ajog.2017.10.014_bib22) 1993; 36 Collins (10.1016/j.ajog.2017.10.014_bib17) 2015; 68 Maher (10.1016/j.ajog.2017.10.014_bib7) 2013; 4 10.1016/j.ajog.2017.10.014_bib24 Milsom (10.1016/j.ajog.2017.10.014_bib1) 2013 Landefeld (10.1016/j.ajog.2017.10.014_bib26) 2008; 148 Lyssenko (10.1016/j.ajog.2017.10.014_bib10) 2008; 359 Wilson (10.1016/j.ajog.2017.10.014_bib12) 2014; 25 Haya (10.1016/j.ajog.2017.10.014_bib4) 2015; 212 Jelovsek (10.1016/j.ajog.2017.10.014_bib15) 2014; 123 White (10.1016/j.ajog.2017.10.014_bib23) 2011; 30 Rockhill (10.1016/j.ajog.2017.10.014_bib30) 2001; 93 Sokol (10.1016/j.ajog.2017.10.014_bib25) 2015; 350 Tegerstedt (10.1016/j.ajog.2017.10.014_bib20) 2005; 58 Coyne (10.1016/j.ajog.2017.10.014_bib2) 2008; 101 |
References_xml | – volume: 123 start-page: 279 year: 2014 end-page: 287 ident: bib15 article-title: A model for predicting the risk of de novo stress urinary incontinence in women undergoing pelvic organ prolapse surgery publication-title: Obstet Gynecol – volume: 350 year: 2015 ident: bib25 article-title: Update on the UK law on consent publication-title: BMJ – start-page: 1685 year: 2012 end-page: 1712 ident: bib3 article-title: Economics of urinary and faecal incontinence, and prolapse publication-title: Incontinence – start-page: CD006375 year: 2015 ident: bib6 article-title: Mid-urethral sling operations for stress urinary incontinence in women publication-title: Cochrane Database Syst Rev – volume: 286 start-page: 180 year: 2001 end-page: 187 ident: bib9 article-title: Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation publication-title: JAMA – volume: 120 start-page: 144 year: 2013 end-page: 151 ident: bib18 article-title: The prevalence of urinary incontinence 20 years after childbirth: a national cohort study in singleton primiparae after vaginal or caesarean delivery publication-title: BJOG – volume: 389 start-page: 393 year: 2017 end-page: 402 ident: bib28 article-title: Pelvic floor muscle training for secondary prevention of pelvic organ prolapse (PREVPROL): a multicentre randomised controlled trial publication-title: Lancet – reference: Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001. – volume: 148 start-page: 449 year: 2008 end-page: 458 ident: bib26 article-title: National Institutes of Health state-of-the-science conference statement: prevention of fecal and urinary incontinence in adults publication-title: Ann Intern Med – volume: 101 start-page: 1388 year: 2008 end-page: 1395 ident: bib2 article-title: The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study publication-title: BJU Int – volume: 36 start-page: 77 year: 1993 end-page: 97 ident: bib22 article-title: Etiology and management of fecal incontinence publication-title: Dis Colon Rectum – volume: 118 start-page: 1001 year: 2011 end-page: 1007 ident: bib14 article-title: Exclusive caesarean section delivery and subsequent urinary and faecal incontinence: a 12-year longitudinal study publication-title: BJOG – volume: 93 start-page: 358 year: 2001 end-page: 366 ident: bib30 article-title: Validation of the Gail et al model of breast cancer risk prediction and implications for chemoprevention publication-title: J Natl Cancer Inst – reference: NIDDK, Office of Research on Women’s H, National Institute on A. Prevention of Lower Urinary Tract Symptoms in Women: Bladder Health Clinical Centers (PLUS-CCs) (U01). National Institutes of Health, 2014 website: – volume: 25 start-page: 1449 year: 2014 end-page: 1452 ident: bib12 article-title: UR-CHOICE: can we provide mothers-to-be with information about the risk of future pelvic floor dysfunction? publication-title: Int Urogynecol J – volume: 123 start-page: 1201 year: 2014 end-page: 1206 ident: bib5 article-title: Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery publication-title: Obstet Gynecol – volume: 212 start-page: 755.e1 year: 2015 end-page: 755.e27 ident: bib4 article-title: Prolapse and continence surgery in countries of the Organization for Economic Cooperation and Development in 2012 publication-title: Am J Obstet Gynecol – volume: 68 start-page: 134 year: 2015 end-page: 143 ident: bib17 article-title: Transparent reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement publication-title: J Clin Epidemiol – start-page: 15 year: 2013 end-page: 108 ident: bib1 article-title: Epidemiology of urinary incontinence (UI) and other lower urinary tract symptoms (LUTS), pelvic organ prolapse (POP) and anal incontinence (AI) publication-title: 5th International Consultation on Incontinence – volume: 4 start-page: CD004014 year: 2013 ident: bib7 article-title: Surgical management of pelvic organ prolapse in women publication-title: Cochrane Database Syst Rev – reference: National Cancer I. Theory at a glance: a guide for health promotion practice. US Department of Health and Human Services, National Institutes of Health; 2012 (vol 2016). – volume: 47 start-page: 497 year: 1993 end-page: 499 ident: bib21 article-title: Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey publication-title: J Epidemiol Community Health – reference: . – volume: 36 start-page: 536 year: 2016 end-page: 540 ident: bib16 article-title: The wisdom of crowds of doctors: their average predictions outperform their individual ones publication-title: Med Decis Making – volume: 30 start-page: 377 year: 2011 end-page: 399 ident: bib23 article-title: Multiple imputation using chained equations: issues and guidance for practice publication-title: Stat Med – volume: 19 start-page: 110 year: 2013 end-page: 118 ident: bib11 article-title: Prediction models for postpartum urinary and fecal incontinence in primiparous women publication-title: Female Pelvic Med Reconstr Surg – volume: 120 start-page: 152 year: 2013 end-page: 160 ident: bib13 article-title: Prevalence and risk factors for pelvic organ prolapse 20 years after childbirth: a national cohort study in singleton primiparae after vaginal or caesarean delivery publication-title: BJOG – volume: 116 start-page: 25 year: 2009 end-page: 31 ident: bib19 article-title: Psychometric properties of the pelvic organ prolapse symptom score publication-title: BJOG – volume: 359 start-page: 2220 year: 2008 end-page: 2232 ident: bib10 article-title: Clinical risk factors, DNA variants, and the development of type 2 diabetes publication-title: N Engl J Med – volume: 108 start-page: 1517 year: 2006 end-page: 1529 ident: bib27 article-title: Cesarean delivery on maternal request: maternal and neonatal outcomes publication-title: Obstet Gynecol – volume: 58 start-page: 41 year: 2005 end-page: 46 ident: bib20 article-title: A short-form questionnaire identified genital organ prolapse publication-title: J Clin Epidemiol – volume: 359 start-page: 2220 year: 2008 ident: 10.1016/j.ajog.2017.10.014_bib10 article-title: Clinical risk factors, DNA variants, and the development of type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa0801869 – volume: 389 start-page: 393 year: 2017 ident: 10.1016/j.ajog.2017.10.014_bib28 article-title: Pelvic floor muscle training for secondary prevention of pelvic organ prolapse (PREVPROL): a multicentre randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(16)32109-2 – volume: 101 start-page: 1388 year: 2008 ident: 10.1016/j.ajog.2017.10.014_bib2 article-title: The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study publication-title: BJU Int doi: 10.1111/j.1464-410X.2008.07601.x – ident: 10.1016/j.ajog.2017.10.014_bib29 – ident: 10.1016/j.ajog.2017.10.014_bib8 – volume: 36 start-page: 536 year: 2016 ident: 10.1016/j.ajog.2017.10.014_bib16 article-title: The wisdom of crowds of doctors: their average predictions outperform their individual ones publication-title: Med Decis Making doi: 10.1177/0272989X15581615 – volume: 36 start-page: 77 year: 1993 ident: 10.1016/j.ajog.2017.10.014_bib22 article-title: Etiology and management of fecal incontinence publication-title: Dis Colon Rectum doi: 10.1007/BF02050307 – volume: 120 start-page: 144 year: 2013 ident: 10.1016/j.ajog.2017.10.014_bib18 article-title: The prevalence of urinary incontinence 20 years after childbirth: a national cohort study in singleton primiparae after vaginal or caesarean delivery publication-title: BJOG doi: 10.1111/j.1471-0528.2012.03301.x – volume: 68 start-page: 134 year: 2015 ident: 10.1016/j.ajog.2017.10.014_bib17 article-title: Transparent reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2014.11.010 – volume: 25 start-page: 1449 year: 2014 ident: 10.1016/j.ajog.2017.10.014_bib12 article-title: UR-CHOICE: can we provide mothers-to-be with information about the risk of future pelvic floor dysfunction? publication-title: Int Urogynecol J doi: 10.1007/s00192-014-2376-z – start-page: 15 year: 2013 ident: 10.1016/j.ajog.2017.10.014_bib1 article-title: Epidemiology of urinary incontinence (UI) and other lower urinary tract symptoms (LUTS), pelvic organ prolapse (POP) and anal incontinence (AI) – volume: 19 start-page: 110 year: 2013 ident: 10.1016/j.ajog.2017.10.014_bib11 article-title: Prediction models for postpartum urinary and fecal incontinence in primiparous women publication-title: Female Pelvic Med Reconstr Surg doi: 10.1097/SPV.0b013e31828508f0 – volume: 58 start-page: 41 year: 2005 ident: 10.1016/j.ajog.2017.10.014_bib20 article-title: A short-form questionnaire identified genital organ prolapse publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2004.06.008 – volume: 108 start-page: 1517 year: 2006 ident: 10.1016/j.ajog.2017.10.014_bib27 article-title: Cesarean delivery on maternal request: maternal and neonatal outcomes publication-title: Obstet Gynecol doi: 10.1097/01.AOG.0000241092.79282.87 – start-page: 1685 year: 2012 ident: 10.1016/j.ajog.2017.10.014_bib3 article-title: Economics of urinary and faecal incontinence, and prolapse – ident: 10.1016/j.ajog.2017.10.014_bib24 doi: 10.1007/978-1-4757-3462-1 – volume: 30 start-page: 377 year: 2011 ident: 10.1016/j.ajog.2017.10.014_bib23 article-title: Multiple imputation using chained equations: issues and guidance for practice publication-title: Stat Med doi: 10.1002/sim.4067 – volume: 212 start-page: 755.e1 year: 2015 ident: 10.1016/j.ajog.2017.10.014_bib4 article-title: Prolapse and continence surgery in countries of the Organization for Economic Cooperation and Development in 2012 publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2015.02.017 – volume: 118 start-page: 1001 year: 2011 ident: 10.1016/j.ajog.2017.10.014_bib14 article-title: Exclusive caesarean section delivery and subsequent urinary and faecal incontinence: a 12-year longitudinal study publication-title: BJOG doi: 10.1111/j.1471-0528.2011.02964.x – start-page: CD006375 year: 2015 ident: 10.1016/j.ajog.2017.10.014_bib6 article-title: Mid-urethral sling operations for stress urinary incontinence in women publication-title: Cochrane Database Syst Rev – volume: 123 start-page: 279 year: 2014 ident: 10.1016/j.ajog.2017.10.014_bib15 article-title: A model for predicting the risk of de novo stress urinary incontinence in women undergoing pelvic organ prolapse surgery publication-title: Obstet Gynecol doi: 10.1097/AOG.0000000000000094 – volume: 93 start-page: 358 year: 2001 ident: 10.1016/j.ajog.2017.10.014_bib30 article-title: Validation of the Gail et al model of breast cancer risk prediction and implications for chemoprevention publication-title: J Natl Cancer Inst doi: 10.1093/jnci/93.5.358 – volume: 4 start-page: CD004014 year: 2013 ident: 10.1016/j.ajog.2017.10.014_bib7 article-title: Surgical management of pelvic organ prolapse in women publication-title: Cochrane Database Syst Rev – volume: 120 start-page: 152 year: 2013 ident: 10.1016/j.ajog.2017.10.014_bib13 article-title: Prevalence and risk factors for pelvic organ prolapse 20 years after childbirth: a national cohort study in singleton primiparae after vaginal or caesarean delivery publication-title: BJOG doi: 10.1111/1471-0528.12020 – volume: 47 start-page: 497 year: 1993 ident: 10.1016/j.ajog.2017.10.014_bib21 article-title: Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey publication-title: J Epidemiol Community Health doi: 10.1136/jech.47.6.497 – volume: 286 start-page: 180 year: 2001 ident: 10.1016/j.ajog.2017.10.014_bib9 article-title: Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation publication-title: JAMA doi: 10.1001/jama.286.2.180 – volume: 350 year: 2015 ident: 10.1016/j.ajog.2017.10.014_bib25 article-title: Update on the UK law on consent publication-title: BMJ doi: 10.1136/bmj.h1481 – volume: 123 start-page: 1201 year: 2014 ident: 10.1016/j.ajog.2017.10.014_bib5 article-title: Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery publication-title: Obstet Gynecol doi: 10.1097/AOG.0000000000000286 – volume: 148 start-page: 449 year: 2008 ident: 10.1016/j.ajog.2017.10.014_bib26 article-title: National Institutes of Health state-of-the-science conference statement: prevention of fecal and urinary incontinence in adults publication-title: Ann Intern Med doi: 10.7326/0003-4819-148-6-200803180-00210 – volume: 116 start-page: 25 year: 2009 ident: 10.1016/j.ajog.2017.10.014_bib19 article-title: Psychometric properties of the pelvic organ prolapse symptom score publication-title: BJOG doi: 10.1111/j.1471-0528.2008.01903.x |
SSID | ssj0002292 |
Score | 2.5281997 |
Snippet | Little progress has been made in the prevention of pelvic floor disorders, despite their significant health and economic impact. The identification of women... Little progress has been made in preventing pelvic floor disorders despite their significant health and economic impact. Identifying women at risk remains a... |
SourceID | swepub proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 222.e1 |
SubjectTerms | Adult Decision Support Techniques fecal incontinence Female Gynaecology, Obstetrics and Reproductive Medicine Gynekologi, obstetrik och reproduktionsmedicin Humans Logistic Models Longitudinal Studies machine learning Multivariate Analysis Parturition pelvic floor disorder Pelvic Floor Disorders - diagnosis Pelvic Floor Disorders - etiology pelvic organ prolapse prediction model Prognosis Prospective Studies Reproducibility of Results Risk Assessment Risk Factors Self Report urinary incontinence |
Title | Predicting risk of pelvic floor disorders 12 and 20 years after delivery |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S000293781731205X https://dx.doi.org/10.1016/j.ajog.2017.10.014 https://www.ncbi.nlm.nih.gov/pubmed/29056536 https://www.proquest.com/docview/1954398045 https://gup.ub.gu.se/publication/258814 |
Volume | 218 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB6SDZReSt_ZtA0qlF6Kk9XLso4hNGxbEnpoYG_Cei0Ji73s45BLf3tGa9nQlqbQmy15QIzGM5_QNzMAHxyCUFpKWygZbCGUiIUVdSKuRWHrUgm3695weVVOr8XXmZztwXmfC5Noldn3dz59563zyGnW5uny5ibl-E4wVqmKKk7ZRM724YBxXcoRHJx9-Ta9GhwyY5r1KDgJ5NyZjuZV37bzxPBSJ4nkRcXf4tOf-PO34qK7gHTxFJ5kJEnOusU-g73QPIdHl_mu_AVMv6_Sc6I1k0QgJ20ky7BAz0Diom1XxOfCm2tCGakbT9iE3KHhr8mucTjxYZFIG3cv4fri84_zaZH7JhROVHpT1J45abWKvNTeVY5J7oVXiMwqi_EZleajtpFJFiOL1PnaMe5DiDJaPB0y_gpGTduEQyCaTXjlnJPBI7TTvObSMhGlw1OhVaUfA-21ZVwuKp56WyxMzx67NUnDJmk4jaGGx_BpkFl2JTUe_Jr3m2D6ZFF0bwY9_oNScpD6xZz-Kfe-32eD_1m6PKmb0G7XJlXG47pCBDyG150BDKtnGmGk5OUYPnYWMcyk4t3z7dLg0Hxr1sEwWVVUHP3n8t7AY3yrOtb4WxhtVtvwDkHRxh7D_slPepxN_x4N6glv |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LixQxEC7WFdSL-FzHZwTxIr07nUcnOcriMurO4mEX5hY6r2GXoXuYx2Ev_nYr3ekRFVfw1iQpCJXqqi_kqyqAdw5BaFkJW0gRbMElj4XldSKuRW7rSnLXdW-YnlWTC_5lJmZ7cDzkwiRaZfb9vU_vvHUeOcraPFpeXqYc3zHGKqlKyUo6FrNbcJsLJhOv7_D7T54HpZoOGDgtz5kzPcmrvmrnid8lDxPFq-R_i05_os_fSot24ejkAdzPOJJ87Lf6EPZC8wjuTPNL-WOYfFul70RqJok-TtpIlmGBfoHERduuiM9lN9ekpKRuPKFjco1mvyZd23DiwyJRNq6fwMXJp_PjSZG7JhSOK70pak-dsFpGVmnvlKOCee4l4jJlMTqjynzUNlJBY6SxdL52lPkQoogW74aUPYX9pm3CMyCajplyzongEdhpVjNhKY_C4Z3QysqPoBy0ZVwuKZ46WyzMwB27MknDJmk4jaGGR_BhJ7PsC2rcuJoNh2CGVFF0bgb9_Y1SYif1izH9U-7tcM4G_7L0dFI3od2uTaqLx7RC_DuCg94AdrunGkGkYNUI3vcWsZtJpbvn26XBofnWrIOhQqmSP__P7b2Bu5Pz6ak5_Xz29QXcwxnV88dfwv5mtQ2vEB5t7OvO_H8AS6gKOg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predicting+risk+of+pelvic+floor+disorders+12+and+20+years+after+delivery&rft.jtitle=American+journal+of+obstetrics+and+gynecology&rft.au=Jelovsek%2C+J.+Eric&rft.au=Chagin%2C+Kevin&rft.au=Gyhagen%2C+Maria&rft.au=Hagen%2C+Suzanne&rft.date=2018-02-01&rft.pub=Elsevier+Inc&rft.issn=0002-9378&rft.volume=218&rft.issue=2&rft.spage=222.e1&rft.epage=222.e19&rft_id=info:doi/10.1016%2Fj.ajog.2017.10.014&rft.externalDocID=S000293781731205X |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9378&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9378&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9378&client=summon |